Skip to main content
HOWL
NASDAQ Life Sciences

Institutional Investor MPM Discloses Over $812K in Recent Share Sales Amidst Strategic Review

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.495
Mkt Cap
$24.07M
52W Low
$0.493
52W High
$2.38
52W Position info
0.4% above low
Off High info
79% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

HOWL is trading near its 52-week low of $0.493 (0.4% above the low).

Summary

Institutional investor MPM BioVentures has disclosed over $812,000 in recent share sales, adding to an ongoing pattern of distribution as the company faces financial uncertainty and explores strategic options.


Key Events · Ownership and Investor Activity · HOWL

  • Institutional Investor Sales

    MPM BioVentures, an institutional shareholder, disclosed over $812,000 in recent share sales from April 27 to May 13, 2026, as detailed in the attached exhibits.

  • Ongoing Distribution Pattern

    This filing is part of a broader pattern of distribution by institutional investors, with over $1.1 million in net insider sales over the last 90 days.

  • Strategic Alternatives & Going Concern

    The sales occur as Werewolf Therapeutics explores strategic alternatives and has previously reported substantial doubt about its ability to continue as a going concern.

  • Trading Near 52-Week Low

    The sales are taking place while the company's stock is trading near its 52-week low of $0.4931, indicating selling into weakness.


Analysis · HOWL · Life Sciences

MPM BioVentures, a significant institutional shareholder, has disclosed over $812,000 in recent share sales, continuing a pattern of distribution. This ongoing selling by a major investor, especially while the stock trades near its 52-week low and the company explores strategic alternatives, suggests a lack of confidence in the company's near-term prospects. The company previously reported substantial doubt about its ability to continue as a going concern.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $24.1M. The 52-week trading range was $0.49 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.9836
Real-time Price: $0.9935 info
Change: +$0.0099 (+1%) info
Market Cap: $48.103M info
HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.9935 info
Change: +$0.0235 (+2%) info
Market Cap: $48.103M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.9935 info
Change: -$0.0065 (-0.65%) info
Market Cap: $48.103M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $0.9935 info
Change: +$0.0129 (+1%) info
Market Cap: $48.103M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $0.9935 info
Change: +$0.0228 (+2%) info
Market Cap: $48.103M info